Introduction
AIMP1, also known as EMPA2 or p43, is a cytokine released during apoptosis. It plays a role in regulating angiogenesis (blood vessel formation), inflammation, and wound healing. AIMP1 can sensitize blood vessels associated with tumors, making them more susceptible to the effects of tumor necrosis factor (TNF). Additionally, when broken down within tumor cells, AIMP1 can trigger inflammatory responses.
Description
This product consists of a recombinant human AIMP1 protein that has been engineered to include a 20 amino acid His tag at its N-terminus. It is produced in E. coli and exists as a single, non-glycosylated polypeptide chain comprising 356 amino acids (specifically, amino acids 1-336 of the AIMP1 sequence). The molecular weight of the protein is 39.2 kDa, although it might appear larger on SDS-PAGE. The purification of AIMP1 is achieved using proprietary chromatographic methods.
Physical Appearance
A clear and colorless solution that has been sterilized by filtration.
Formulation
The AIMP1 protein is provided at a concentration of 0.25 mg/ml in a buffer solution containing 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 2 mM DTT, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. The addition of a carrier protein like 0.1% HSA or BSA is suggested for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of this product is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
Aminoacyl tRNA synthase complex-interacting multifunctional protein 1, Multisynthase complex auxiliary component p43, AIMP1, EMAP2, SCYE1, p43, EMAPII.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MLPAVAVSEP VVLRFMIFCR LLAKMANNDA VLKRLEQKGA EADQIIEYLK QQVSLLKEKA ILQATLREEK KLRVENAKLK KEIEELKQEL IQAEIQNGVK QIPFPSGTPL HANSMVSENV IQSTAVTTVS SGTKEQIKGG TGDEKKAKEK IEKKGEKKEK KQQSIAGSAD SKPIDVSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQMQNRM VILLCNLKPA KMRGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTNDECVA TYKGVPFEVK GKGVCRAQTM SNSGIK.